Ilube

Moorfields Pharmaceuticals has extended its ophthalmic portfolio with the acquisition of Ilube 5% w/v Eye Drops (Aceytylcysteine) from Alcon Laboratories (UK).

The new owner is the pharmaceutical manufacturing Unit of the world-famous, Moorfields Eye Hospital, and in recent years Moorfields Pharmaceuticals has used their expertise to establish a strong business supplying a broad range of ophthalmic specials to the UK and Ireland.

Moorfields Pharmaceuticals has identified dry eye syndrome as a significant area of need and opportunity. The company plans to focus on dry eye syndrome and launch a continuum of therapies over the next 12 to 24 months, this includes the purchase of Ilube 5% w/v Eye Drops (Aceytylcysteine).

Customers are advised that all orders and enquiries relating to this product should now be made to the Moorfields Pharmaceuticals customer services team on: 02076849090, or email pharmaceuticals@moorfields.nhs.uk

About Ilube 5% w/v Eye Drops .

Ilube eye drops are artificial tears with mucolytic and lubrication properties. This treatment can relieve dry eye conditions which are associated with a lack of tears or abnormal mucus production. Ilube eye drops work by reducing the stickiness of mucus in the eye and lubricate dry eyes, thus relieving any discomfort.